|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription
|
 |
|
Title:
|
 |
Estrogen related receptor-gamma ligand binding domain complexed with a rip140 peptide and synthetic ligand gsk4716
|
|
Structure:
|
 |
Estrogen-related receptor gamma. Chain: a, b. Fragment: residues (229-458). Synonym: estrogen receptor-related protein 3, err gamma-2. Engineered: yes. Nuclear receptor-interacting protein 1. Chain: c, d. Fragment: residues (366-390). Synonym: nuclear factor rip140, receptor-interacting protein 140.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: esrrg. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Other_details: chemically synthesized. Occurs naturally in humans.
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.233
|
R-free:
|
0.257
|
|
|
Authors:
|
 |
L.Wang,W.J.Zuercher,T.G.Consler,M.H.Lambert,A.B.Miller,L.A.Osband- Miller,D.D.Mckee,T.M.Willson,R.T.Nolte
|
Key ref:
|
 |
L.Wang
et al.
(2006).
X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
J Biol Chem,
281,
37773-37781.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
18-Apr-06
|
Release date:
|
26-Sep-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P62508
(ERR3_HUMAN) -
Estrogen-related receptor gamma from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
458 a.a.
225 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
281:37773-37781
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.
|
|
L.Wang,
W.J.Zuercher,
T.G.Consler,
M.H.Lambert,
A.B.Miller,
L.A.Orband-Miller,
D.D.McKee,
T.M.Willson,
R.T.Nolte.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
X-ray crystal structures of the ligand binding domain (LBD) of the
estrogen-related receptor-gamma (ERRgamma) were determined that describe this
receptor in three distinct states: unliganded, inverse agonist bound, and
agonist bound. Two structures were solved for the unliganded state, the ERRgamma
LBD alone, and in complex with a coregulator peptide representing a portion of
receptor interacting protein 140 (RIP140). No significant differences were seen
between these structures that both exhibited the conformation of ERRgamma seen
in studies with other coactivators. Two structures were obtained describing the
inverse agonist-bound state, the ERRgamma LBD with 4-hydroxytamoxifen (4-OHT),
and the ERRgamma LBD with 4-OHT and a peptide representing a portion of the
silencing mediator of retinoid and thyroid hormone action protein (SMRT). The
4-OHT structure was similar to other reported inverse agonist bound structures,
showing reorientation of phenylalanine 435 and a displacement of the AF-2 helix
relative to the unliganded structures with little other rearrangement occurring.
No significant changes to the LBD appear to be induced by peptide binding with
the addition of the SMRT peptide to the ERRgamma plus 4-OHT complex. The
observed agonist-bound state contains the ERRgamma LBD, a ligand (GSK4716), and
the RIP140 peptide and reveals an unexpected rearrangement of the phenol-binding
residues. Thermal stability studies show that agonist binding leads to global
stabilization of the ligand binding domain. In contrast to the conventional
mechanism of nuclear receptor ligand activation, activation of ERRgamma by
GSK4716 does not appear to involve a major rearrangement or significant
stabilization of the C-terminal helix.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
FIGURE 4. ERR ·4-OHT·SMRT
complex. The tetrameric assembly containing four of the six
molecules in the asymmetric unit is shown. A ribbon
representation of the ERR monomers is shown with
each monomer shown with a distinct color: yellow, molecule A;
magenta, molecule B; blue, molecule C; and green, molecule D.
The ligand is depicted as a stick figure with orange carbon
atoms. Residues 319-330 of the SMRT peptide are depicted as cyan
ribbons with peptide chain G binding ERR chain A and peptide
chain H binding ERR chain B. The remaining
two molecules in the asymmetric unit form a similar tetramer
with symmetrically related copies of themselves around a
crystallographic 2-fold axis.
|
 |
Figure 7.
FIGURE 7. Plot of ligand interactions in the ERR ·GSK4716·RIP140
complex. Hydrogen bonds involving the ligand are shown in red,
with distances denoted in angstroms. The ligand hydrogen bonds
directly to two residues, the side chain of Asp-328 and the back
bone carbonyl of Tyr-327. Indirect hydrogen bonds to the ligand
exist through two waters to the side chain of Arg-316 and the
main chain of Leu-309. Residues denoted in blue are >4.0 Å
from the ligand.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2006,
281,
37773-37781)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.Deblois,
and
V.Giguère
(2013).
Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond.
|
| |
Nat Rev Cancer,
13,
27-36.
|
 |
|
|
|
|
 |
M.Koh,
and
S.B.Park
(2011).
Computer-aided design and synthesis of tetra-aryl-substituted alkenes and their bioevaluation as a selective modulator of estrogen-related receptor γ.
|
| |
Mol Divers,
15,
69-81.
|
 |
|
|
|
|
 |
R.Berry,
L.Harewood,
L.Pei,
M.Fisher,
D.Brownstein,
A.Ross,
W.A.Alaynick,
J.Moss,
N.D.Hastie,
P.Hohenstein,
J.A.Davies,
R.M.Evans,
and
D.R.Fitzpatrick
(2011).
Esrrg functions in early branch generation of the ureteric bud and is essential for normal development of the renal papilla.
|
| |
Hum Mol Genet,
20,
917-926.
|
 |
|
|
|
|
 |
A.le Maire,
C.Teyssier,
C.Erb,
M.Grimaldi,
S.Alvarez,
A.R.de Lera,
P.Balaguer,
H.Gronemeyer,
C.A.Royer,
P.Germain,
and
W.Bourguet
(2010).
A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor.
|
| |
Nat Struct Mol Biol,
17,
801-807.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.le Maire,
W.Bourguet,
and
P.Balaguer
(2010).
A structural view of nuclear hormone receptor: endocrine disruptor interactions.
|
| |
Cell Mol Life Sci,
67,
1219-1237.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Phelan,
R.T.Gampe,
M.H.Lambert,
D.J.Parks,
V.Montana,
J.Bynum,
T.M.Broderick,
X.Hu,
S.P.Williams,
R.T.Nolte,
and
M.A.Lazar
(2010).
Structure of Rev-erbalpha bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction.
|
| |
Nat Struct Mol Biol,
17,
808-814.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.J.Andersen,
N.R.Mawji,
J.Wang,
G.Wang,
S.Haile,
J.K.Myung,
K.Watt,
T.Tam,
Y.C.Yang,
C.A.Bañuelos,
D.E.Williams,
I.J.McEwan,
Y.Wang,
and
M.D.Sadar
(2010).
Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor.
|
| |
Cancer Cell,
17,
535-546.
|
 |
|
|
|
|
 |
S.M.Rangwala,
X.Wang,
J.A.Calvo,
L.Lindsley,
Y.Zhang,
G.Deyneko,
V.Beaulieu,
J.Gao,
G.Turner,
and
J.Markovits
(2010).
Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity.
|
| |
J Biol Chem,
285,
22619-22629.
|
 |
|
|
|
|
 |
S.Mukherjee,
and
S.Mani
(2010).
Orphan nuclear receptors as targets for drug development.
|
| |
Pharm Res,
27,
1439-1468.
|
 |
|
|
|
|
 |
X.Liu,
A.Matsushima,
H.Okada,
and
Y.Shimohigashi
(2010).
Distinction of the binding modes for human nuclear receptor ERRgamma between bisphenol A and 4-hydroxytamoxifen.
|
| |
J Biochem,
148,
247-254.
|
 |
|
|
|
|
 |
A.Ao,
H.Wang,
S.Kamarajugadda,
and
J.Lu
(2008).
Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors.
|
| |
Proc Natl Acad Sci U S A,
105,
7821-7826.
|
 |
|
|
|
|
 |
H.Okada,
T.Tokunaga,
X.Liu,
S.Takayanagi,
A.Matsushima,
and
Y.Shimohigashi
(2008).
Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma.
|
| |
Environ Health Perspect,
116,
32-38.
|
 |
|
|
|
|
 |
A.M.Tremblay,
and
V.Giguère
(2007).
The NR3B subgroup: an ovERRview.
|
| |
Nucl Recept Signal,
5,
e009.
|
 |
|
|
|
|
 |
A.R.de Lera,
W.Bourguet,
L.Altucci,
and
H.Gronemeyer
(2007).
Design of selective nuclear receptor modulators: RAR and RXR as a case study.
|
| |
Nat Rev Drug Discov,
6,
811-820.
|
 |
|
|
|
|
 |
S.M.Hyatt,
E.L.Lockamy,
R.A.Stein,
D.P.McDonnell,
A.B.Miller,
L.A.Orband-Miller,
T.M.Willson,
and
W.J.Zuercher
(2007).
On the intractability of estrogen-related receptor alpha as a target for activation by small molecules.
|
| |
J Med Chem,
50,
6722-6724.
|
 |
|
|
|
|
 |
S.Raghuram,
K.R.Stayrook,
P.Huang,
P.M.Rogers,
A.K.Nosie,
D.B.McClure,
L.L.Burris,
S.Khorasanizadeh,
T.P.Burris,
and
F.Rastinejad
(2007).
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta.
|
| |
Nat Struct Mol Biol,
14,
1207-1213.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|